Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NewGenIvf Group Limited

    NASDAQ: NIVF · Real-Time Price · USD
    0.93
    -0.06 (-6.06%)
    At close: Jul 03, 2025, 3:57 PM

    NewGenIvf Statistics

    Share Statistics

    NewGenIvf has 4.3M shares outstanding. The number of shares has increased by -89.99% in one year.

    Shares Outstanding

    n/a
    		 4.3M

    Shares Change (YoY)

    n/a
    		 -89.99%

    Shares Change (QoQ)

    n/a
    		 -90%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 3.87M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 367.55K, so 34.98% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 367.55K

    Short % of Shares Out

    n/a
    		 34.98%

    Short % of Float

    n/a
    		 35.67%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -8.79 and the forward PE ratio is null. NewGenIvf's PEG ratio is 0.09.

    PE Ratio

    n/a
    		 -8.79

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.85

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -4.4

    P/FCF Ratio

    n/a
    		 -0.55

    PEG Ratio

    n/a
    		 0.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for NewGenIvf.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.17, with a Debt / Equity ratio of -2.89.

    Current Ratio

    n/a
    		 1.17

    Quick Ratio

    n/a
    		 1.14

    Debt / Equity

    n/a
    		 -2.89

    Debt / EBITDA

    n/a
    		 125.67

    Debt / FCF

    n/a
    		 -0.36

    Interest Coverage

    n/a
    		 -1.49

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $71,486.84

    Profits Per Employee

    n/a
    		 $-6,907.89

    Employee Count

    n/a
    		 76

    Asset Turnover

    n/a
    		 1.52

    Inventory Turnover

    n/a
    		 44.63

    Taxes

    Income Tax

    n/a
    		 -487K

    Effective Tax Rate

    n/a
    		 50.66%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.13, so NewGenIvf's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.13

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 2.35

    200-Day Moving Average

    n/a
    		 58.51

    Relative Strength Index (RSI)

    n/a
    		 30.96

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    In the last 12 months, NewGenIvf had revenue of 5.43M and earned -525K in profits. Earnings per share was -4.61.

    Revenue

    n/a
    		 5.43M

    Gross Profit

    n/a
    		 1.83M

    Operating Income

    n/a
    		 -1.16M

    Net Income

    n/a
    		 -525K

    EBITDA

    n/a
    		 24.11K

    EBIT

    n/a
    		 -182K

    Earnings Per Share (EPS)

    n/a
    		 -4.61
    Full Income Statement

    Balance Sheet

    The company has 457.74K in cash and 3.03M in debt, giving a net cash position of -2.57M.

    Cash & Cash Equivalents

    n/a
    		 457.74K

    Total Debt

    n/a
    		 3.03M

    Net Cash

    n/a
    		 -2.57M

    Retained Earnings

    n/a
    		 -985.99K

    Total Assets

    n/a
    		 3.78M

    Working Capital

    n/a
    		 452.39K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.26M and capital expenditures -53.04K, giving a free cash flow of -8.32M.

    Operating Cash Flow

    n/a
    		 -8.26M

    Capital Expenditures

    n/a
    		 -53.04K

    Free Cash Flow

    n/a
    		 -8.32M

    FCF Per Share

    n/a
    		 -7.31
    Full Cash Flow Statement

    Margins

    Gross margin is 33.62%, with operating and profit margins of -21.36% and -9.66%.

    Gross Margin

    n/a
    		 33.62%

    Operating Margin

    n/a
    		 -21.36%

    Pretax Margin

    n/a
    		 -17.68%

    Profit Margin

    n/a
    		 -9.66%

    EBITDA Margin

    n/a
    		 0.44%

    EBIT Margin

    n/a
    		 -21.35%

    FCF Margin

    n/a
    		 -153.09%

    Dividends & Yields

    NIVF does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for NIVF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 5, 2025. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 May 5, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -0.21

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist